StrykerSYK
About: Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Employees: 53,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
90% more first-time investments, than exits
New positions opened: 152 | Existing positions closed: 80
2% more funds holding
Funds holding: 1,949 [Q2] → 1,991 (+42) [Q3]
10% more repeat investments, than reductions
Existing positions increased: 781 | Existing positions reduced: 712
4% more capital invested
Capital invested by funds: $106B [Q2] → $110B (+$4.09B) [Q3]
9% less call options, than puts
Call options by funds: $586M | Put options by funds: $641M
1.61% less ownership
Funds ownership: 81.69% [Q2] → 80.07% (-1.61%) [Q3]
3% less funds holding in top 10
Funds holding in top 10: 77 [Q2] → 75 (-2) [Q3]
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
11 analyst ratings
Barclays Matt Miksic 82% 1-year accuracy 31 / 38 met price target | 15%upside $443 | Overweight Maintained | 10 Feb 2025 |
Goldman Sachs David Roman 54% 1-year accuracy 7 / 13 met price target | 11%upside $427 | Neutral Maintained | 30 Jan 2025 |
Truist Securities Richard Newitter 74% 1-year accuracy 31 / 42 met price target | 7%upside $413 | Hold Maintained | 30 Jan 2025 |
RBC Capital Shagun Singh 61% 1-year accuracy 41 / 67 met price target | 13%upside $435 | Outperform Maintained | 29 Jan 2025 |
Wells Fargo Larry Biegelsen 63% 1-year accuracy 30 / 48 met price target | 13%upside $435 | Overweight Maintained | 29 Jan 2025 |
Financial journalist opinion
Based on 23 articles about SYK published over the past 30 days









